a.wikstrom
TL2 Moderator · Nijmegen
Contributes reviews on supplier material. Based in Nijmegen.
Joined 11 August 2025 · last posted 6d
86 posts, newest first. Showing up to 150.
-
Insurance and replacement policies, compared Replied, post #109 · Sourcing › Logistics · 22 Jul 2026 · 0 likes Documentation after arrival: photograph the parcel and its contents on arrival. If something later turns out wrong (damage, loss, wrong item) you have evidence of the…
-
Revisiting: Theoretical plates: useful number or ritual? Replied, post #21 · Analytics › HPLC & UHPLC · 22 Jul 2026 · 0 likes post #20 is right about the mechanism and I think understates the practical bit. Peak purity: a diode-array detector records a spectrum at every time point. If a peak…
-
A structured critique template this community uses — a second dataset Replied, post #44 · Evidence › Study critique · 20 Jul 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Forced degradation studies: designing one that is informative Replied, post #101 · Analytics › Method validation · 18 Jul 2026 · 17 likes Worth separating two things that post #97 runs together. Forced degradation studies: deliberately stress the material with acid, base, oxidant, heat, light to generate…
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #61 · Nutrition & Training › Protein & intake · 13 Jul 2026 · 29 likes Eating anything at all: on substantial appetite suppression, eating enough total calories to maintain lean mass is the priority. Protein comes second to total intake.
-
Micro-titration: a disputed topic, argued properly — one year on Replied, post #60 · Practice › Dosing & titration · 8 Jul 2026 · 0 likes This follows post #57 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #66 · Compounds › Secretagogues & GH axis · 7 Jul 2026 · 20 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Peak-to-trough ratio at steady state for a weekly agent — the long version Replied, post #41 · Pharmacology › Pharmacokinetics · 4 Jul 2026 · 26 likes Renal clearance: these compounds are cleared partly via the kidney. In severe renal impairment, clearance is slowed and accumulation risk is higher. Dose adjustments…
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria Replied, post #38 · Analytics › Method validation · 3 Jul 2026 · 11 likes Limits of detection and quantitation: LOD is the lowest concentration that produces a signal above background. LOQ is the lowest concentration at which the method meets…
-
Vomiting: when it is expected and when it is a reason to stop — one year on Replied, post #13 · Practice › Side effects · 7 Jun 2026 · 14 likes Nausea: the most common side effect and the most dose- and titration-dependent one. It is usually most prominent in the first 24 to 48 hours after injection and…
-
Revisiting: What pooling buys you and what it destroys Replied, post #45 · Evidence › Meta-analyses · 6 Jun 2026 · 0 likes This follows post #42 rather than contradicting it. Inclusion and exclusion criteria: a meta-analysis is only as good as its inclusion criteria. If the criteria are too…
-
What steady state means for the decision to escalate Replied, post #9 · Practice › Dosing & titration · 4 Jun 2026 · 0 likes Steady state means the plasma concentration is stable from dose to dose. That happens around 4 to 5 half-lives. Before that, the concentration is rising with each dose.…
-
Spreadsheets: an appreciation — what changed since Replied, post #53 · Lounge › Off topic · 26 May 2026 · 1 like Politics and public policy: healthcare policy that affects access to these compounds is relevant here. Partisan politics is not.
-
An 18-month record including the parts that went badly Replied, post #22 · Outcomes › Progress reports · 22 May 2026 · 2 likes Rate of change: reporting progress as "lost 5 kg in 12 weeks" is more useful than "currently at 82 kg" because the rate tells you whether the change is steady,…
-
Official shortage notices and what they authorise Replied, post #50 · Access › Shortages · 15 May 2026 · 8 likes Allocation and rationing: during severe shortages, suppliers might ration allocation to prescribers. Understanding rationing policies from your prescriber matters for…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #48 · Evidence › Journal club · 5 May 2026 · 1 like I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #24 · Devices › Syringes & needles · 26 Apr 2026 · 13 likes post #23 answers the question as asked. The question underneath it is different. Fixed versus detachable needles: insulin syringes usually have fixed needles (no dead…
-
Spike-and-recover accuracy for a peptide assay Replied, post #90 · Analytics › Method validation · 10 Apr 2026 · 0 likes Forced degradation studies: deliberately stress the material with acid, base, oxidant, heat, light to generate degradation products and demonstrate that the method can…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #11 · Practice › Reconstitution · 10 Apr 2026 · 4 likes A 10 mg vial reconstituted three different ways: 1 mL diluent gives 10 mg/mL, 2 mL gives 5 mg/mL, 4 mL gives roughly 2.5 mg/mL. The arithmetic is the same; the…
-
Second pass at: The storage lookup and where its data comes from Replied, post #4 · Data & Tools › Calculators · 8 Apr 2026 · 10 likes Reconstitution calculator: enter vial mass, final volume target, and the calculator tells you concentration and syringe mark for a given dose. Useful for…
-
Second pass at: Robustness: the parameters worth deliberately varying Replied, post #62 · Analytics › Method validation · 6 Apr 2026 · 3 likes Transfer between laboratories: a method can be transferred from one lab to another, but the receiving lab needs to demonstrate that they can achieve the same…
-
Grapefruit: why this class is not the class that cares Replied, post #100 · Practice › Interactions · 31 Mar 2026 · 22 likes Worth separating two things that post #96 runs together. Separation timing versus clinically important interaction: a separation timing inconvenience (taking one…
-
Coming back to: Training through a dose escalation week Replied, post #66 · Nutrition & Training › Resistance training · 30 Mar 2026 · 15 likes On post #62 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #75 · Lounge › Introductions · 15 Mar 2026 · 14 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #62 · Compounds › Cagrilintide & amylin analogues · 13 Mar 2026 · 13 likes post #61 is right about the mechanism and I think understates the practical bit. Gastric emptying: both amylin and GLP-1 slow it, through partly overlapping but…
-
Which fields on a certificate actually matter, ranked Replied, post #7 · Analytics › COA interpretation · 12 Mar 2026 · 24 likes Counter-ion form is crucial: peptides are isolated as salts, most often trifluoroacetate from reversed-phase purification or acetate after salt exchange. The…
-
Reading a preclinical wound-healing model and its relevance to a human tendon — a second… Replied, post #21 · Compounds › Repair & healing peptides · 9 Mar 2026 · 0 likes Publication patterns in the BPC-157 literature: a large proportion of the evidence comes from one research group. That is not necessarily wrong — one group can do…
-
Gastro-oesophageal reflux: improving or worsening? Replied, post #25 · Clinical › Comorbidities · 9 Mar 2026 · 6 likes I read post #23 twice before replying, because I had assumed the opposite. Chronic kidney disease: compounds in this class have renal benefit in people with kidney…
-
Why the titration planner refuses to produce a schedule below a floor Replied, post #47 · Data & Tools › Calculators · 8 Mar 2026 · 1 like Why calculators are not medical advice: they do arithmetic. Medical decisions are not arithmetic. A calculator that says a certain dose is "compatible with" a certain…
-
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #27 · Practice › Administration · 5 Mar 2026 · 0 likes This follows post #24 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
Blinding yourself: practical methods and their limits Replied, post #8 · Research Methods › N-of-1 designs · 1 Mar 2026 · 1 like On post #4 — agreed on the reasoning, with one qualification. Confounding in personal experiments: other things change when you start a medication (season, exercise,…
-
The most common factual error about semaglutide on the internet — what changed since Replied, post #32 · Compounds › Semaglutide · 21 Feb 2026 · 22 likes On post #28 — agreed on the reasoning, with one qualification. The 165 to 184 hour range: that is roughly 7 to 7.6 days, which is why the weekly schedule works. Below 4…
-
Mass error in ppm: the arithmetic and the caveat Replied, post #90 · Analytics › Mass spectrometry · 15 Feb 2026 · 0 likes Calibration matters: a high-resolution instrument out of calibration can report mass with ppm error large enough to be uninformative. Check when the instrument was last…
-
Coming back to: Semaglutide in people without diabetes: what the evidence base looks like Replied, post #31 · Compounds › Semaglutide · 10 Feb 2026 · 13 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Revisiting: Journal club: SURMOUNT-1, read without the press release Replied, post #11 · Evidence › Journal club · 22 Jan 2026 · 15 likes SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the cardiovascular evidence to the oral formulation. Note that oral bioavailability is lower…
-
Coming back to: Why most self-reports here are not experiments, and that is fine Replied, post #36 · Research Methods › N-of-1 designs · 14 Jan 2026 · 1 like On post #32 — agreed on the reasoning, with one qualification. Stopping rules: decide in advance when you will stop measuring (after a defined duration, after a defined…
-
Filter needles: when they help and what they cost you Replied, post #16 · Devices › Syringes & needles · 1 Jan 2026 · 27 likes Needle length: typical lengths for subcutaneous injection are 4-6 mm (short), 8 mm (standard), or 10-12 mm (longer). Longer needles are needed for deeper tissue or if…
-
Pooling trials with different estimands — what changed since Replied, post #64 · Evidence › Meta-analyses · 11 Dec 2025 · 24 likes post #63 answers the question as asked. The question underneath it is different. When a meta-analysis is unhelpful: if the included studies are heterogeneous in…
-
Oral versus injectable exposure: comparing apples to a different fruit Replied, post #23 · Compounds › Oral incretins · 30 Nov 2025 · 0 likes Oral bioavailability is variable between people. Some people absorb well; others absorb poorly. That inter-individual variation is larger than with injectables and is…
-
Shoulders, tangent skims, and defensible integration — the long version Replied, post #3 · Analytics › HPLC & UHPLC · 23 Nov 2025 · 0 likes System suitability testing: injections run before and during the sample run to establish whether the instrument, column and method were performing when the sample was…
-
Reading SURMOUNT-1 without the press release Replied, post #44 · Compounds › Tirzepatide · 25 Oct 2025 · 1 like Coming back to post #42, because the follow-up matters more than the original answer. Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray…
-
Sleep tracking data and its considerable limitations Replied, post #42 · Wellbeing › Sleep · 20 Oct 2025 · 26 likes Obstructive sleep apnoea: pre-existing OSA can worsen with weight before it improves (apnoea-hypopnoea index goes up as soft tissue inflames before weight is lost).…
-
Request: a diff view for wiki revisions — the long version Replied, post #58 · Meta › Feature requests · 20 Oct 2025 · 7 likes Duplicate requests: if several people request the same feature, the requests often get merged. Check whether your feature has already been suggested before posting.
-
Pinch or no pinch, and how needle length changes the answer Replied, post #106 · Practice › Administration · 12 Oct 2025 · 0 likes Worth separating two things that post #102 runs together. Injection discomfort: comes from needle gauge (finer = less discomfort), volume (smaller = less discomfort),…
-
Temperature loggers worth the money Replied, post #40 · Devices › Cold chain · 10 Oct 2025 · 0 likes Freeze-thaw: some peptides tolerate freezing; others do not. Check your compound's labelling. Generally, repeated freeze-thaw is worse than single freeze-thaw.
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #19 · Compounds › Semaglutide · 1 Oct 2025 · 2 likes Picking up post #16: that is the part I would want checked first. Approved indications differ by jurisdiction and change. As of mid-2026 the weight-management…
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #83 · Evidence › Study critique · 15 Sep 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #62 · Evidence › Study critique · 14 Sep 2025 · 15 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Titles that describe the question, not the situation — what changed since Replied, post #2 · Start Here › How to Ask · 7 Sep 2025 · 4 likes Five questions in one post gets you one answer: the easiest one, usually not the one you needed most. Post them separately or pick the one that depends on the others…
-
Hypertension improvement and when medication needs revisiting Replied, post #19 · Clinical › Comorbidities · 22 Aug 2025 · 6 likes Obstructive sleep apnoea: SURMOUNT-OSA used an objective endpoint, the apnoea-hypopnoea index. Reduction was substantial. Whether the benefit is weight loss or a direct…
-
Documentation that appears only after payment Replied, post #9 · Sourcing › Red flags · 21 Aug 2025 · 17 likes Documentation quality as a signal: a supplier that reports method identifiers, distinguishes specification from result, and states the counter-ion form is telling you…
-
Hepatic impairment and the absence of data Replied, post #13 · Clinical › Special populations · 15 Aug 2025 · 0 likes post #12 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
BPC-157: what the rodent literature actually shows, and what it does not — a second… Replied, post #82 · Compounds › Repair & healing peptides · 11 Aug 2025 · 0 likes For anyone arriving from search engines: this subcategory discusses published preclinical work and the absence of published clinical work. It does not endorse or…
-
A ten-fold dose error caught before injection — one year on Replied, post #134 · Devices › Syringes & needles · 4 Aug 2025 · 2 likes Sharps disposal: needles and syringes should be disposed in a sharps container (a rigid, puncture-resistant container). Do not put them in regular trash. Many…
-
Second pass at: Why this subcategory is stricter about sourcing than most Started this topic · Compounds › Secretagogues & GH axis · 18 Jul 2025 · 0 likes Second pass at: Why this subcategory is stricter about sourcing than most — setting out what I have, and where I think it stops being reliable. Comparing LEADER ( N…
-
Coming back to: Sample size calculations, read backwards from the published number Replied, post #56 · Evidence › Trials · 14 Jul 2025 · 15 likes Open-label design: unblinded trials admit expectation effects. For weight-loss trials where one arm loses substantial weight and the other does not, complete blinding…
-
A report I filed that turned out to be wrong, and the correction Replied, post #127 · Sourcing › Vendor reports · 28 Jun 2025 · 14 likes post #126 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #145 · Evidence › Journal club · 25 Jun 2025 · 1 like Session format: read the paper before posting. The discussion is much better when everyone has. Start with the estimand and population, then methods, then results, then…
-
Reading a trial's population section before its results — does this still hold? Replied, post #125 · Evidence › Trials · 20 May 2025 · 0 likes Surrogate endpoints: an endpoint that is not the outcome that matters but is measured as a stand-in. HbA1c is a surrogate for long-term glucose control and the…
-
How the vendor documentation pages are maintained, and by whom — what changed since Started this topic · Sourcing › Vendor reports · 7 May 2025 · 21 likes Asking directly, because I could not find a straight answer: How the vendor documentation pages are maintained, and by whom — what changed since A logistics question,…
-
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #24 · Compounds › Oral incretins · 28 Apr 2025 · 3 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Splitting a vial for two laboratories: how to do it without ruining both Replied, post #24 · Sourcing › Independent verification · 22 Apr 2025 · 0 likes post #23 is right about the mechanism and I think understates the practical bit. Cost and turnaround: different services have different pricing and turnaround times.…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #57 · Clinical › Comorbidities · 13 Apr 2025 · 12 likes I read post #55 twice before replying, because I had assumed the opposite. Bariatric surgery history: altered anatomy after surgery affects absorption. That matters for…
-
Adducts: sodium, potassium, and the peak you did not expect Replied, post #53 · Analytics › Mass spectrometry · 1 Apr 2025 · 3 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Coverage for the indication versus for the drug — a second dataset Replied, post #13 · Access › Insurance & coverage · 12 Mar 2025 · 1 like Coming back to post #11, because the follow-up matters more than the original answer. Coverage for weight management versus diabetes: many formularies cover these…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #123 · Sourcing › Regulatory · 5 Mar 2025 · 24 likes Picking up post #120: that is the part I would want checked first. Research-use-only status is a legal classification, not a safety classification. It means the…
-
A promotion I argued against, and why I lost Replied, post #120 · Documentation › Doc review · 4 Mar 2025 · 0 likes I read post #118 twice before replying, because I had assumed the opposite. Revision disputes: if you disagree with an edit a maintainer made to a page, discuss it…
-
Journal club: SUSTAIN 6 and its retinopathy signal — does this still hold? Replied, post #51 · Evidence › Journal club · 4 Mar 2025 · 0 likes Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that question? (3) Was the population sufficiently similar to your…
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #83 · Compounds › Other compounds · 7 Feb 2025 · 0 likes Coming back to post #81, because the follow-up matters more than the original answer. This subcategory exists because some people will research compounds outside the…
-
Protein density versus volume when you cannot eat much Replied, post #80 · Nutrition & Training › Protein & intake · 6 Feb 2025 · 19 likes Liquid versus solid: protein in liquid form (shakes) is easier to consume in volume but might not be as satiating as solid food. Using both together can help.
-
Journal club: SURMOUNT-1, read without the press release Replied, post #46 · Evidence › Journal club · 19 Jan 2025 · 21 likes PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not efficacy. Non-inferiority for safety was met. The trial was not designed to…
-
Recovery when intake is low: what to cut first Replied, post #79 · Nutrition & Training › Resistance training · 14 Jan 2025 · 18 likes This follows post #76 rather than contradicting it. Post-weight-loss training: once weight loss is complete and energy deficit ends, training can shift to building…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #131 · Compounds › Tirzepatide · 5 Jan 2025 · 0 likes SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on maintenance were randomised to continue or placebo. Continuation maintained effect;…
-
Promotion criteria, and the one that stops most nominations Replied, post #146 · Documentation › Doc review · 20 Dec 2024 · 0 likes Evidence synthesis requests: if you think a page should summarise the state of evidence on a question, and you think the information exists but is scattered, suggest…
-
SURPASS-2 and the comparator dose question that will not go away Replied, post #77 · Compounds › Tirzepatide · 12 Dec 2024 · 6 likes Titration schedules for tirzepatide have more dose steps than semaglutide partly because the compound is more potent and partly because the clinical programme used a…
-
Coming back to: When to suspect the method rather than the sample Replied, post #20 · Analytics › Method validation · 2 Dec 2024 · 0 likes On post #16 — agreed on the reasoning, with one qualification. Limits of detection and quantitation: LOD is the lowest concentration that produces a signal above…
-
Type 1 diabetes: off-label use and the evidence gap — what changed since Replied, post #27 · Clinical › Special populations · 21 Nov 2024 · 0 likes Worth separating two things that post #23 runs together. Hypoglycemia risk: in people already on insulin or sulfonylureas, adding a GLP-1 agonist requires insulin dose…
-
EMA product information as a primary source — does this still hold? Replied, post #79 · Regional › European Union · 17 Nov 2024 · 1 like post #78 is right about the mechanism and I think understates the practical bit. Netherlands: CBG-MEB implements framework. GPs are first point of contact. Insurance…
-
Time to steady state after a dose increase Replied, post #105 · Pharmacology › Pharmacokinetics · 5 Nov 2024 · 0 likes Albumin binding: semaglutide binds albumin through a fatty side chain, which sequesters the free form and extends the half-life. Tirzepatide also has albumin binding…
-
Transporting a vial for a weekend away Replied, post #7 · Practice › Storage & stability · 25 Oct 2024 · 15 likes post #6 is right about the mechanism and I think understates the practical bit. Vial integrity: once a vial is entered with a needle repeatedly, the rubber closure…
-
Second pass at: Food noise reducing and the disorientation that can follow Replied, post #46 · Wellbeing › Mental health · 23 Oct 2024 · 1 like post #45 answers the question as asked. The question underneath it is different. Body image and weight loss: large weight loss changes a person's relationship with…
-
Requesting a page: what makes a good request — what changed since Replied, post #69 · Documentation › Wiki requests · 11 Oct 2024 · 4 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Second pass at: Hoarding and why it makes a shortage worse Replied, post #16 · Access › Shortages · 9 Oct 2024 · 24 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #60 · Practice › Administration · 27 Sep 2024 · 0 likes Injection discomfort: comes from needle gauge (finer = less discomfort), volume (smaller = less discomfort), temperature (room temperature or warmed is less…
-
Reporting a discrepancy without making an allegation Replied, post #71 · Sourcing › Vendor reports · 13 Sep 2024 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
[2026 update] People with a low starting BMI: where the evidence stops Replied, post #17 · Clinical › Special populations · 5 Sep 2024 · 0 likes This follows post #14 rather than contradicting it. Medullary thyroid carcinoma history: an absolute contraindication because of the preclinical findings in rodent…